Hemarus Llc

What Hemarus Llc does

Hemarus LLC is a privately-held, FDA-licensed plasma collection company operating a single walk-in plasma donation center at 11925 Beach Blvd., Suite 212, Jacksonville, Florida, with a corporate office at 4745 Sutton Park Court in the same metro. The company is structured as an LLC domiciled in Florida and operates as a direct-to-consumer donor center targeting healthy adults aged 18–65, who are compensated up to $800 per month for plasma donations.

Hemarus's core service is the collection of human source plasma under cGMP (current Good Manufacturing Practices) compliance, using high-tech plasmapheresis equipment designed to shorten donation time while preserving donor safety and plasma quality. Donors are onboarded through a four-step flow (check-in, screening, physical exam, donation) with required documentation including valid photo ID, proof of Social Security Number, and proof of address. The company additionally operates a specialty antibody donor program offering higher compensation for donors with rare antibodies, positioning the center to supply both standard and hyperimmune plasma.

Commercially, Hemarus functions as a B2B supplier in the plasma fractionation supply chain. Donated plasma is sold as raw material to pharmaceutical manufacturers that produce therapies for hemophilia, immune deficiencies, trauma and shock, and burn-related injuries. Pricing to donors is structured as usage-based compensation (pay-as-you-go, up to $800/month for standard donations, higher for specialty antibodies), while revenue from the buyer side flows as a per-liter transaction fee from fractionators. The company markets through organic social channels (Facebook, LinkedIn, X), maintains no disclosed partnerships or institutional investors, and competes on regulatory compliance, donor experience (free Wi-Fi, certified staff, quarterly raffle), and operating convenience (walk-ins accepted).

Name

Hemarus Llc

Legal name

Hemarus LLC

Website

https://hemarus.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Hemarus LLC operates an FDA-licensed, cGMP-compliant plasma donation center in Jacksonville, Florida. It collects source and specialty antibody plasma from compensated walk-in donors and supplies it as raw material to pharmaceutical manufacturers producing therapies for rare diseases and blood disorders.

Ownership category

akta.pro rank

Product category

Plasma Collection Services

NAICS

Blood and Organ Banks (621991)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

Keywords

• Plasma collection services
• Source plasma supply
• Biopharmaceutical raw materials
• Plasma donation center
• FDA licensed plasma

Headquarters

HQ city

Lauderhill

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Plasma Collection and Sale: Hemarus collects human normal plasma from donors at FDA licensed facilities. The plasma is sold as a raw material to pharmaceutical companies for the production of life-saving therapies and medications for treating rare diseases, immune deficiencies, and blood disorders.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Hemarus LLC operates an FDA-licensed plasma donation center in Jacksonville, Florida, that collects human normal plasma (and specialty hyperimmune plasma) from compensated individual donors. The collected plasma is sold as a raw material to pharmaceutical companies for the fractionation and manufacture of life-saving therapies used to treat hemophilia, immune deficiencies, trauma, and blood disorders. The company enforces cGMP and operates a walk-in donation facility with high-tech collection equipment.

Product overview

Hemarus LLC operates as a single-service plasma donation center, offering plasma collection services at its FDA-licensed facility. The company collects human normal plasma through a donor screening and donation process, with donors compensated up to $800 per month. Plasma collected is used to manufacture life-saving therapies for patients with rare diseases, immune deficiencies, hemophilia, and trauma/burn victims. The offering is a unified service model rather than a platform-plus-modules architecture.

Differentiator

Problem solved

Functional benefit

Products and services

• Plasma Donation Services

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Vitalant: Vitalant is a large nonprofit blood collection network that also collects source plasma. Comparable in donor collection operations and FDA-regulated model, but broader (whole blood, platelets) and nonprofit, unlike Hemarus' paid source plasma model.

Others

• American Red Cross Blood Services: The American Red Cross operates the largest U.S. blood and plasma collection infrastructure. Comparable as a donor-screening, FDA-licensed plasma collection entity, but is a nonprofit and does not pay donors like Hemarus.

Direct peers

• BPL Plasma: BPL Plasma operates a network of FDA-licensed source plasma collection centers in the U.S. supplying BPL's fractionation business. Highly comparable to Hemarus in operational and regulatory model.
• Kedrion Biopharma (Plasma): Kedrion collects source plasma in the U.S. via its own plasma center network to supply its plasma-derived therapeutics business. Directly comparable as an FDA-licensed operator competing in the same donor market as Hemarus.
• Octapharma Plasma: Octapharma Plasma runs a network of U.S. source plasma donation centers supplying Octapharma's fractionation business. Directly comparable to Hemarus in center operations, donor compensation, and FDA licensing model.
• Grifols Plasma: Grifols operates hundreds of plasma collection centers in the U.S. that feed its Biopharma division. Comparable to Hemarus in operating model, regulatory requirements, and donor compensation, but at vastly greater scale.
• Immunotek Bio Centers: Immunotek operates multiple U.S. plasma collection centers focused on source plasma supply. Comparable mid-sized independent operator competing with Hemarus for donors in shared U.S. geographies.
• BioLife Plasma Services: BioLife, owned by Takeda, operates a large U.S. network of paid plasma donation centers. It directly competes with Hemarus for the same donor demographic with similar compensation structures and downstream supply to a major fractionator.
• CSL Plasma: CSL Plasma operates one of the world's largest networks of FDA-licensed source plasma collection centers, serving CSL Behring's fractionation needs. It is the closest direct competitor to Hemarus in plasma collection model, donor compensation structure, and downstream pharma supply.

Emerging players

• ADMA Biologics: ADMA Biologics operates FDA-licensed plasma collection centers focused on hyperimmune and specialty antibody plasma, supplying its proprietary immune globulin portfolio. Comparable to Hemarus' specialty program focus, though vertically integrated into manufacturing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/HemarusP
• Facebookfacebook.com/pages/category/Blood-Bank/Hemarus-Plasma-Donations-711495735703238
• LinkedInlinkedin.com/company/hemarus-llc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemarus Llc